Skip to main content
Skin Health and Disease logoLink to Skin Health and Disease
. 2023 Sep 4;3(5):e281. doi: 10.1002/ski2.281

Vulvar lichen sclerosus in pregnancy: Unaddressed needs and systematic review

Britt Debaene 1, Sander Vandeweege 1, Hans Verstraelen 2,3,
PMCID: PMC10549801  PMID: 37799355

Abstract

Women with vulvar lichen sclerosus (vLS) often express their concern over disease course, treatment, and complications relating to vLS in pregnancy and following childbirth. We used such patient concerns as study objectives in a systematic literature research. Although few, mostly low‐quality studies have been published on that matter, and albeit the vast majority of women will have stable vLS during pregnancy, available data also suggest that in a small but significant proportion of patients, pregnancy and delivery may complicate the course of vLS and vice versa.

graphic file with name SKI2-3-e281-g001.jpg


Dear Editor, vulvar lichen sclerosus (vLS) is a chronic inflammatory skin condition that may affect the anogenital area in women of any age. Treatment of vLS with high‐potency topical corticosteroids (TCS) and emollients/moisturizers should be assumed for life, regardless of symptoms, and further adjusted to disease activity. 1 Apart from providing symptomatic relief, long‐term maintenance therapy is key in maintaining disease remission, in reducing the risk of scarring and loss of vulvar anatomy, and, notably, in minimising the risk of squamous cell carcinoma in vLS. 2 , 3

In clinical practice we perceive a defined patients' needs however, for information on disease course in relation to pregnancy and childbirth. Obstetric health care providers in turn may not be familiar with vLS. We therefore listed a set of topical patients' questions and concerns, and further sought to provide answers through a systematic literature search in line with the PRISMA statement, 4 and according to a preregistered protocol (Prospero CRD42023411358). 5 Specifically, we searched MEDLINE, EMBASE, and Web of Science, without limits or language restriction, up to 12 February 2023 and further cross‐checked reference lists of selected studies. Studies were considered eligible if these addressed at least one of the following questions: Does pregnancy alter the disease course of vLS?; Does or may vLS necessitate delivery by primary caesarean section?; Is there an increased risk for perineal tears with vLS?; May vLS delay or complicate healing of episiotomy and/or perineal tears?; and, does vLS worsen following delivery? Eligibility screening of records retrieved was performed independently by all authors. Risk of bias was assessed through use of the appropriate JBI tool for the respective study designs. 6 , 7

In this manner, we retrieved eight studies, published between 1991 and 2021, with data on pregnancy and/or delivery in a total of 177 vLS patients (sample size range, 2–92) (Table 1). Except for a single nested case‐control study, all studies were uncontrolled and except for one prospective study, all studies had a retrospective case series design.

TABLE 1.

Overview of studies on vulvar lichen sclerosus in women giving birth.

Study Country Study design Sample size Methods Outcomes
  • Helm et al. 1991 10

USA Retrospective, case series N = 11 Self‐report (questionnaire) Disease course
USA Retrospective, case series N = 9 Self‐report (questionnaire) Disease course; delivery mode
  • Haefner et al. 1999 12

USA Retrospective, case series N = 2 Clinical chart review Disease course
  • Günthert et al. 2008 13

Germany Retrospective, case series N = 4 Clinical chart review Disease course
  • Higgins et al. 2012 14

UK Retrospective, nested case‐control study N = 92 (compared to 66 controls) Self‐report (questionnaire) Delivery mode; perineal tears and healing
  • Nguyen et al. 2018 15

Australia Retrospective, case series N = 29 (33 pregnancies) Clinical chart review Disease course; compliance, delivery mode; perineal and abdominal scar healing
  • Trokoudes et al. 2019 16

UK Prospective, case series N = 22 (36 pregnancies) Self‐report Disease course; delivery mode; episiotomy and perineal tear rates
  • Kolitz et al. 2021 17

USA Retrospective, case series N = 8 Clinical chart review Disease course

Both worsening of vLS, not otherwise specified (reported in two studies, with worsening in 5 of 11, and 2 of 8 patients, respectively), as well as improvement during pregnancy (reported in three studies, with improvement in 5 of 11, 3 of 9, and 4 of 4 patients, respectively) was reported, while absence of an observed effect of pregnancy on vLS was by far the most common outcome across studies (reported in four studies, with an absence of effect on vLS in all 33 pregnancies in 29 patients, in all 36 pregnancies in 22 patients, and in 5 of 9, and 6 of 8 patients in two previously listed studies, respectively). Overall, disease course of vLS during pregnancy was reported in 7 out of 8 studies, relating to a total of 85 women, of which 12 patients experienced improvement, 65 women had stable vLS, and 7 patients reported worsening. Notably, in 5 patients, vLS reportedly developed, either was first diagnosed in pregnancy (reported in two studies, with onset and/or first diagnosis in 1 of 11, and 4 of 29 patients, respectively). Delivery through caesarean was attributed to vLS (in one patient owing to non‐compliance) in a single patient in two studies each (1 of 11, and 1 of 29 patients, respectively). In only one patient was there a suggestion of vLS‐related risk for perineal tears (1 of 9 patients, relating to 4 deliveries). One study also mentioned delayed healing of a third degree tear in one patient not under treatment (1 of 22 patients), while in another study development of vLS/koebnerization in the area of the perineal scar occurred (1 of 29 patients). Finally, worsening of vLS in the postpartum was mentioned only once with regard to three pregnancies in one woman (one study, 1 of 9 patients).

Overall, there were few studies on vLS in pregnancy. Studies were rather small, mostly retrospective and uncontrolled, rarely used standardized measures such as TCS need, and often provided little detail on treatment altogether, and therefore particularly prone to bias. Hence, no meaningful estimates can be made on the incidence of outcomes addressed. Nonetheless, the small literature base retrieved, suggests that in an apparently small proportion of patients, pregnancy and delivery may complicate the course of vLS and vice versa. Specifically, vLS was reported to possibly worsen in pregnancy, and in a few cases, to necessitate caesarean delivery, to underlie perineal trauma, and to delay or complicate perineal wound healing. While it cannot be inferred from these data whether this is also preventable, a number of complications of vLS are in fact largely prevented by long‐term topical treatment. 2 , 8 Furthermore, cases were described with onset either first diagnosis in pregnancy suggesting that prenatal care may provide a window of opportunity to early diagnosis and treatment of vLS.

In conclusion, while there is a defined need for prospective data on vLS in pregnancy, currently available data do suggest that in a majority of vLS patients under treatment, pregnancy does not complicate vLS and vice versa. Nonetheless, early diagnosis and proper treatment remain key, also in pregnancy, in order to possibly avoid negative outcomes relating to vLS in pregnancy. Recently published guidelines on that matter, 9 as well as efforts to increase vulvar awareness among obstetric health care providers may further benefit women with vLS during and following pregnancy.

CONFLICT OF INTEREST STATEMENT

None to declare.

AUTHOR CONTRIBUTIONS

Britt Debaene: Data curation (supporting); formal analysis (lead); methodology (supporting); project administration (lead); validation (supporting); visualization (lead); writing—review & editing (equal). Sander Vandeweege: Data curation (supporting); formal analysis (lead); methodology (supporting); project administration (lead); validation (supporting); visualization (lead); writing—review & editing (equal). Hans Verstraelen: Conceptualization (lead); data curation (lead); methodology (lead); supervision (lead); writing—original draft (lead); writing—review & editing (lead).

ETHICS STATEMENT

Not applicable.

Supporting information

Supporting Information S1

Supporting Information S2

ACKNOWLEDGEMENTS

Not applicable.

Debaene B, Vandeweege S, Verstraelen H. Vulvar lichen sclerosus in pregnancy: unaddressed needs and systematic review. Skin Health Dis. 2023;3(5):e281. 10.1002/ski2.281

DATA AVAILABILITY STATEMENT

The data that supports the findings of this study are available in the supplementary material of this article.

REFERENCES

  • 1. Lee A, Fischer G. Diagnosis and treatment of vulvar lichen sclerosus: an update for dermatologists. Am J Clin Dermatol. 2018;19(5):695–706. 10.1007/s40257-018-0364-7 [DOI] [PubMed] [Google Scholar]
  • 2. Lee A, Bradford J, Fischer G. Long‐term management of adult vulvar lichen sclerosus: a prospective cohort study of 507 women. JAMA Dermatol. 2015;151(10):1061–1067. 10.1001/jamadermatol.2015.0643 [DOI] [PubMed] [Google Scholar]
  • 3. Vieira‐Baptista P, Pérez‐López FR, López‐Baena MT, Stockdale CK, Preti M, Bornstein J. Risk of development of vulvar cancer in women with lichen sclerosus or lichen planus: a systematic review. J Low Genit Tract Dis. 2022;26(3):250–257. 10.1097/lgt.0000000000000673 [DOI] [PubMed] [Google Scholar]
  • 4. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372(3):n71. 10.1371/journal.pmed.1003583 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. The International Prospective Register of Systematic Reviews (PROSPERO). [2023 Apr 12]. Available from: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=411358
  • 6. Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A, et al. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth. 2020;18:2127–2133. [DOI] [PubMed] [Google Scholar]
  • 7. Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, et al. Chapter 7: Systematic reviews of etiology and risk. In: Aromataris E, Munn Z, editors. Joanna Briggs Institute Reviewer's Manual. The Joanna Briggs Institute; 2017. [2023 Apr 12]. Available form: https://reviewersmanual.joannabriggs.org/ [Google Scholar]
  • 8. Wijaya M, Lee G, Fischer G, Lee A. Quality of life in vulvar lichen sclerosus patients treated with Long‐term topical corticosteroids. J Low Genit Tract Dis. 2021;25(2):158–165. 10.1097/lgt.0000000000000599 [DOI] [PubMed] [Google Scholar]
  • 9. Kirtschig G, Kinberger M, Kreuter A, Simpson R, Günther A, van Hees C, et al. EuroGuiDerm guideline lichen sclerosus version [1]. June 2023. [2023 July 24]. Available form: https://www.guidelines.edf.one//uploads/attachments/cljzpyj9r1hqqyxjrdbpy2szy‐lichen‐sclerosus‐guideline.pdf
  • 10. Helm KF, Gibson LE, Muller SA. Lichen sclerosus et atrophicus in children and young adults. Pediatr Dermatol. 1991;8:97–101. 10.1111/j.1525-1470.1991.tb00294.x [DOI] [PubMed] [Google Scholar]
  • 11. Dalziel KL. Effect of lichen sclerosus on sexual function and parturition. J Reprod Med. 1995;40:351–354. [PubMed] [Google Scholar]
  • 12. Haefner HK, Pearlman MD, Barclay ML, Selvaggi SM. Lichen sclerosus in pregnancy: presentation of two cases. J Low Genit Tract Dis. 1999;3:260–263. 10.1046/j.1526-0976.1999.34008.x [DOI] [PubMed] [Google Scholar]
  • 13. Günthert AR, Faber M, Knappe G, Hellriegel S, Emons G. Early onset vulvar Lichen Sclerosus in premenopausal women and oral contraceptives. Eur J Obstet Gynecol Reprod Biol. 2008;137:56–60. 10.1016/j.ejogrb.2007.10.005 [DOI] [PubMed] [Google Scholar]
  • 14. Higgins CA, Cruickshank ME. A population‐based case‐control study of aetiological factors associated with vulval lichen sclerosus. J Obstet Gynaecol. 2012;32:271–275. 10.3109/01443615.2011.649320 [DOI] [PubMed] [Google Scholar]
  • 15. Nguyen Y, Bradford J, Fischer G. Lichen sclerosus in pregnancy: a review of 33 cases. Aust N Z J Obstet Gynaecol. 2018;58:686–689. 10.1111/ajo.12812 [DOI] [PubMed] [Google Scholar]
  • 16. Trokoudes D, Lewis FM. Lichen sclerosus – the course during pregnancy and effect on delivery. J Eur Acad Dermatol Venereol. 2019;33:e466–e468. [DOI] [PubMed] [Google Scholar]
  • 17. Kolitz E, Gammon L, Mauskar M. Vulvar lichen sclerosus in women of reproductive age. Proc (Bayl Univ Med Cent). 2021;34:349–351. 10.1080/08998280.2021.1885093 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information S1

Supporting Information S2

Data Availability Statement

The data that supports the findings of this study are available in the supplementary material of this article.


Articles from Skin Health and Disease are provided here courtesy of Wiley

RESOURCES